This food technology is a trillion dollar market


In an effort to lose a few pounds, I recently cut sugar from my diet.

It didn’t seem like a challenge until I thought about the multiple cups of coffee I have each day with sugar.

I tried different calorie-free sugar substitutes and eventually found stevia to be the most tolerable.

Even though Stevia is the best of the bunch – especially compared to Splenda or Sweet’N Low – it still has a long way to go.

You see, with stevia, the molecules responsible for the sweetness are taken from the stevia plant and filtered to make the sweetener.

But these molecules make up less than 1% of the plant, and extracting them is an expensive process.

Not to mention that the filtering methods do not work fully, leaving behind a bitter and unpleasant aftertaste. (I’ll leave the face I do after I finish my morning coffee to your imagination!)

It leaves me wondering if there is anything better.

And it looks like there is …

Synthetic biology has limitless applications

Ingredion, a food and beverage ingredients company, recently launched a product called RealSweet.

RealSweet uses genetically engineered yeast and feeds it sugar, which it converts into the exact same molecules found in stevia.

The result is a sweeter product with no aftertaste since it does not need to be filtered like natural stevia.

Not to mention the fact that it’s cheaper to produce since you don’t grow large amounts of stevia just to use a small portion.

This process of genetically engineering a microbe to make it make a desired molecule or substance is known as synthetic biology.

According to Barron, the total addressable synthetic biology market is close to $ 1 trillion.

This is not a surprising figure given that this technology can be applied to almost any industry ranging from agriculture to alternative fuels.

synthetic biology startups food fuel healthcare

Until now, synthetic biology has been used to commercially create compounds for makeup, food flavors, perfumes, vaccines, and polymers.

And that’s just the beginning…

How to invest in the future of food and more

While you could invest in companies like Ingredion to get into synthetic biology, the real opportunity lies in Amyris Inc. (Nasdaq: AMRS).

It was the company that developed the original product which Ingredion now markets under the name RealSweet.

Amyris’ product portfolio includes food ingredients and compounds for beauty and wellness products.

What’s amazing about Amyris is that it doesn’t wait for other companies to market their products.

Take RealSweet for example. Amyris already owned Purecane, its own private label which was sold in stores before the arrival of Ingredion.

And she does the same in the beauty and wellness arena by developing her own brands like Biossance while partnering with cosmetics companies like Sephora.

This combined approach is why Wall Street expects Amyris to increase revenue from $ 392 million to $ 1.04 billion over the next five years.

That’s a compound annual growth rate of over 21%.

The stock has seen an incredible 350% increase in the past year alone! And it’s not too late to enter.

However, if you’re looking for a more lucrative investment in synthetic biology, check out Strategic fortunes.

At his service, Ian King gives you the opportunity to join a business that is earlier in its growth phase. And it is present in more industries than food and cosmetics.


André Prince

Research analyst, Strategic fortunes

Morning movers

Open until noon Eastern Time.

China Evergrande New Energy Vehicle Group Ltd. (OTC: EVGRF) is the electric vehicle manufacturing subsidiary of the China Evergrande group. It was an asset that the company planned to sell to raise funds to meet its short-term debts. It is up 80% this morning on the news of debt relief solutions for China Evergrande.

China Evergrande Group (OTC: EGRNY), the indebted Chinese real estate developer, is up 22% today. The rise came after struggling debt specialist Marathon Asset Management bought up some of Evergrande’s debt today and announced it will continue to do so at current low prices.

Arqit Quantum Inc. (Nasdaq: ARQQ), a quantum encryption technology company, is on the list today with an 18% increase. This stock has been volatile since its IPO last month, and is on the rise today due to that volatility and lack of real news.

Dollar Tree Inc. (Nasdaq: DLTR), the discount retailer, is up 16% this morning after announcing it would test merchandise priced above a dollar in some locations. The move could help the company cope better with rising prices and higher shipping costs.

Eutelsat Communications SA (OTC: ETCMY) is a French satellite telecommunications company up 13% this morning. The move came after telecommunications mogul Patrick Drahi was revealed to be in talks to buy the company for $ 1.96 billion.

United Natural Foods Inc. (NYSE: UNFI), the organic and natural food wholesaler, is up 8% this morning, continuing its rally from yesterday when it reported fourth quarter results that included the both an increase in profits and income.

Lucid Group Inc. (Nasdaq: LCID), the electric car maker, is up 8% on news of Lucid Air’s production start at its Arizona plant, with deliveries to customers scheduled to begin in October.

TaskUs Inc. (Nasdaq: TASK) provides outsourcing services to businesses around the world and is up 7% today. There is no fundamental reason for the move. It looks like investors have just found an opportunity to buy the recent drop in the stock.

Braskem SA (NYSE: BAK) is a Brazilian company which produces and sells thermoplastic resins and chemicals. The stock is up 7% this morning after the company’s Mexican subsidiary reached an agreement with Petroleos Mexicanos to build a $ 400 million terminal that would supply the subsidiary with ethane, a raw material used to produce. certain types of plastics.

Spirit AeroSystems Holdings Inc. (NYSE: SPR), the aircraft manufacturer, is up 7% this morning after analysts at Bernstein raised the stock to a strong buy and raised their price target expecting the that global air transport resumes in the near future. future.

Source link

Leave A Reply

Your email address will not be published.